Therefore, we compared the inhibitory effect of TGFβ1 on RANKL-induced osteoclastogenesis in PBMs from patients with RA (n = 4) to those from healthy donors (n = 12). This evidence concerns the gene TGFB1 and rheumatoid arthritis.